ACTIVE-3 TICO Trial (NCT04501978)

Therapeutics for Inpatients with COVID-19

A Multi-Center, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized patients with COVID-19.

PI: Emerson Perin, MD, PhD

SPONSOR: National Institute of Allergy and Infectious Diseases (NIAID)

ENROLLMENT COMPLETE

LEARN MORE ABOUT THE STUDY       

Read Flip Book     Read on Phone/Tablet